Deployment of artificial intelligence for point-of-care clinical decision support is in its nascency. Despite the media attention and proliferation of AI studies, translation to clinical practice is ...

The recently released rules for developing an accountable care organization are designed to reach the Triple Aim: improved experience of care, improved health of populations and reduced costs. While ...

The clinical decision support space within the broader healthcare AI market is getting more and more crowded, with startups spawning a plethora of tools that help clinicians complete a variety of ...

Please provide your email address to receive an email when new articles are posted on . The intervention reduced patients’ mean systolic BP by 14.6 mm HG. However, there was no difference between the ...

Sacituzumab Govitecan Versus Docetaxel for Previously Treated Advanced or Metastatic Non–Small Cell Lung Cancer: The Randomized, Open-Label Phase III EVOKE-01 Study The IPSS-M provides important new ...

Please provide your email address to receive an email when new articles are posted on . Patients on the clinical decision support system had greater systolic blood pressure change. Mean systolic blood ...

Clinical decision support systems are intended to provide clinicians assistance at the point of care, but a new study in the Journal of the American Medical Informatics Association suggests these ...

Dr. Eve Cunningham is group vice president and chief of virtual care and digital health at health system Providence and founder of MedPearl. And Providence is getting ready to spin off MedPearl.

The emergence of large language models (LLMs) prompted one research team to compare how well this technology performs compared with traditional clinical decision support systems in identifying ...

It’s no secret that artificial intelligence (AI) tools are quickly becoming integrated into everyday clinical care. From real-time support in the operating room to note-writing assistance and patient ...

STONY BROOK, NY / ACCESSWIRE / June 18, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a global leader in PCR-based DNA technologies, today announced that its molecular diagnostics ...

Artificial intelligence is redefining the future of healthcare in Canada. Former Ontario Ministry of Health Chief ...